Moreover, METTL3 expression was significantly downregulated in sorafenib-resistant HCC tissues (Figure 3(d)), and 75% of HCC patients with high LINC01273 expression showed low METTL3 level (Figure 3(e)). The gene discussed is METTL3; the disease is hepatocellular carcinoma.